FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40631311000001103: Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jun 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2247491000001115 Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2247501000001112 Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fentanyl true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Fentanyl citrate true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Is a Fentanyl 200microgram sublingual tablets sugar free 30 tablet true Inferred relationship Existential restriction modifier
Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has AMP Fenhuma 200microgram sublingual tablets (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start